By Year 
Genomic and transcriptomic landscapes of human brain metastases
Saunus, Jodi M.; Quinn, M. C. J.; Patch, A. M.; Pearson, J. V.; Bailey, P. J.; Cloonan, N.; Nones, K.; Miller, D.; Mariasegaram, M.; Lau, Q.; Jeffree, L.; Khanna, Kum Kum; Chenevix-Trench, G.; Grimmond, S. M.; Simpson, P.; Waddell, Nic; Lakhani, S. R.
Clinical and Experimental Metastasis - 1/03/2015
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
Momeny, Majid; Saunus, Jodi M.; Marturana, Flavia; Reed, Amy E. McCart; Black, Debra; Sala, Gianluca; Iacobelli, Stefano; Holland, Jane D.; Yu, Dihua; Da Silva, Leonard; Simpson, PT; Khanna, Kum Kum; Chenevix-Trench, Georgia; Lakhani, S. R.
ONCOTARGET - 1/02/2015
MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments
Miranda M., Rozali E., Khanna K. K. and Al-Ejeh F.
Oncoscience - 1/02/2015
Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma
de Andrade, Lucas Ferrari; Ngiow, Shin Foong; Stannard, Kimberley; Rusakiewicz, Sylvie; Kalimutho, M.; Khanna, Kum Kum; Tey, Siok-Keen; Takeda, Kazuyoshi; Zitvogel, Laurence; Martinet, Ludovic; Smyth, Mark J.
CANCER RESEARCH - 1/12/2014
Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51
Ward, Ambber; Khanna, Kum Kum; Wiegmans, A.
CANCER TREATMENT REVIEWS - 1/11/2014